General Information of DTT (ID: TT9PB26)

DTT Name Presynaptic density protein 95 (DLG4) DTT Info
Gene Name DLG4

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
1 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tat-NR2B9c DMD6AUX Cerebrovascular ischaemia 8B1Z Phase 3 [1]
------------------------------------------------------------------------------------
18 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-Methyl-2,4-Pentanediol DMD45CU Discovery agent N.A. Investigative [2]
FETAV DMO1N2T Discovery agent N.A. Investigative [3]
Guanosine-5'-Monophosphate DM3SLZK Discovery agent N.A. Investigative [2]
KSG-LDTKNYKQTSV DM5DTMQ Discovery agent N.A. Investigative [3]
KSG-YEKLSSIESDV DMPLFRC Discovery agent N.A. Investigative [3]
N-(3,4-Dichlorophenyl)propyl-ETAV DMTERF6 Discovery agent N.A. Investigative [3]
N-(3,4-Difluorophenyl)propyl-ETAV DMF2D4O Discovery agent N.A. Investigative [3]
N-(Naphthalene-2-yl)ethyl-ETAV DMG8KXR Discovery agent N.A. Investigative [3]
N-Benzyl-ETAV DMNPS4R Discovery agent N.A. Investigative [3]
N-Butyl-ETAV DMY3HEF Discovery agent N.A. Investigative [3]
N-Cyclohexylethyl-ETAV DMCH5M1 Discovery agent N.A. Investigative [3]
N-Cyclohexylmethyl-ETAV DMIC8Z6 Discovery agent N.A. Investigative [3]
N-Ethyl-ETAV DMPTNI8 Discovery agent N.A. Investigative [3]
N-Methyl-ETAV DMP1EF6 Discovery agent N.A. Investigative [3]
N-Phenylethyl-ETAV DM1VSO9 Discovery agent N.A. Investigative [3]
N-Phenylpropyl-ETAV DM90GNC Discovery agent N.A. Investigative [3]
N-Propyl-ETAV DMUTDNV Discovery agent N.A. Investigative [3]
YGRKKRRQRRR-KLSSIESDV DMV89B4 Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 18 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Treatment of stroke with a PSD-95 inhibitor in the gyrencephalic primate brain. Nature. 2012 Feb 29;483(7388):213-7.
2 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
3 Modified peptides as potent inhibitors of the postsynaptic density-95/N-methyl-D-aspartate receptor interaction. J Med Chem. 2008 Oct 23;51(20):6450-9.